These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32223171)

  • 1. Understanding the Thermodynamic Mechanisms Leading to the Binding of Albumin to Lipid Nanocapsules.
    Umerska A; Sapin-Minet A; Parent M; Tajber L; Maincent P; Boudier A
    Langmuir; 2020 Apr; 36(15):4165-4173. PubMed ID: 32223171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface active properties of lipid nanocapsules.
    Mouzouvi CRA; Umerska A; Bigot AK; Saulnier P
    PLoS One; 2017; 12(8):e0179211. PubMed ID: 28796777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants.
    Umerska A; Cassisa V; Matougui N; Joly-Guillou ML; Eveillard M; Saulnier P
    Eur J Pharm Biopharm; 2016 Nov; 108():100-110. PubMed ID: 27597268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanocapsules as a new delivery system in copepods: Toxicity studies and optical imaging.
    Stancheva S; Souissi A; Ibrahim A; Barras A; Spriet C; Souissi S; Boukherroub R
    Colloids Surf B Biointerfaces; 2015 Nov; 135():441-447. PubMed ID: 26280818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination study of intact lipid nanocapsules after intravenous rat administration.
    Lebreton V; Legeay S; Rapenne C; Saulnier P; Lagarce F
    Nanomedicine (Lond); 2024; 19(13):1123-1131. PubMed ID: 38690778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of intact lipid nanocapsules using new quantitative FRET technique.
    Lebreton V; Kaeokhamloed N; Vasylaki A; Hilairet G; Mellinger A; Béjaud J; Saulnier P; Lagarce F; Gattacceca F; Legeay S; Roger E
    J Control Release; 2022 Nov; 351():681-691. PubMed ID: 36191672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological response and cytotoxicity induced by lipid nanocapsules.
    Szwed M; Torgersen ML; Kumari RV; Yadava SK; Pust S; Iversen TG; Skotland T; Giri J; Sandvig K
    J Nanobiotechnology; 2020 Jan; 18(1):5. PubMed ID: 31907052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery.
    Groo AC; Saulnier P; Gimel JC; Gravier J; Ailhas C; Benoit JP; Lagarce F
    Int J Nanomedicine; 2013; 8():4291-302. PubMed ID: 24235827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications.
    Formica ML; Ullio Gamboa GV; Tártara LI; Luna JD; Benoit JP; Palma SD
    Int J Pharm; 2020 Jan; 573():118795. PubMed ID: 31682964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-core nanocapsules are an alternative to the pulmonary delivery and to increase the stability of statins.
    Lorenzoni R; Cordenonsi LM; Davies S; Antonow MB; Medina Diedrich AS; Santos CG; Vitalis GS; Garrastazu G; Buttini F; Sonvico F; Gomes P; Raffin RP
    J Microencapsul; 2019 Jun; 36(4):317-326. PubMed ID: 31159613
    [No Abstract]   [Full Text] [Related]  

  • 11. Low temperature, easy scaling up method for development of smart nanostructure hybrid lipid capsules for drug delivery application.
    Yadava SK; Basu SM; Chauhan M; Sharma K; Pradhan A; V R; Giri J
    Colloids Surf B Biointerfaces; 2020 Jun; 190():110927. PubMed ID: 32169777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inter-nanocarrier and nanocarrier-to-cell transfer assays demonstrate the risk of an immediate unloading of dye from labeled lipid nanocapsules.
    Simonsson C; Bastiat G; Pitorre M; Klymchenko AS; Béjaud J; Mély Y; Benoit JP
    Eur J Pharm Biopharm; 2016 Jan; 98():47-56. PubMed ID: 26522878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.
    Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T
    Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular permeability, intraocular biodistribution of lipid nanocapsule formulation intended for retinal drug delivery.
    Christensen G; Urimi D; Lorenzo-Soler L; Schipper N; Paquet-Durand F
    Eur J Pharm Biopharm; 2023 Jun; 187():175-183. PubMed ID: 37088247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer-free hydrogel made of lipid nanocapsules, as a local drug delivery platform.
    Pitorre M; Gazaille C; Pham LTT; Frankova K; Béjaud J; Lautram N; Riou J; Perrot R; Geneviève F; Moal V; Benoit JP; Bastiat G
    Mater Sci Eng C Mater Biol Appl; 2021 Jul; 126():112188. PubMed ID: 34082987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of lipid nanocapsules in different cochlear cell populations after round window membrane permeation.
    Zou J; Saulnier P; Perrier T; Zhang Y; Manninen T; Toppila E; Pyykkö I
    J Biomed Mater Res B Appl Biomater; 2008 Oct; 87(1):10-8. PubMed ID: 18437698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of lung fibrosis after a single pulmonary delivery of lipid nanocapsules in rats.
    Hureaux J; Lacoeuille F; Lagarce F; Rousselet MC; Contini A; Saulnier P; Benoit JP; Urban T
    Int J Nanomedicine; 2017; 12():8159-8170. PubMed ID: 29184405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal lipid nanocapsules for systemic delivery of nimodipine into the brain: In vitro optimization and in vivo pharmacokinetic study.
    Mohsen K; Azzazy HME; Allam NK; Basalious EB
    Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111236. PubMed ID: 32806316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-Core Nanocapsules Act as a Drug Shuttle Through the Blood Brain Barrier and Reduce Glioblastoma After Intravenous or Oral Administration.
    Rodrigues SF; Fiel LA; Shimada AL; Pereira NR; Guterres SS; Pohlmann AR; Farsky SH
    J Biomed Nanotechnol; 2016 May; 12(5):986-1000. PubMed ID: 27305820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation development and upscaling of lipid nanocapsules as a drug delivery system for a novel cyclic GMP analogue intended for retinal drug delivery.
    Urimi D; Widenbring R; Pérez García RO; Gedda L; Edwards K; Loftsson T; Schipper N
    Int J Pharm; 2021 Jun; 602():120640. PubMed ID: 33901599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.